Ondine Biomedical (UK) Investor Sentiment

OBI Stock   7.75  0.25  3.12%   
About 61% of Ondine Biomedical's investor base is looking to short. The analysis of the overall investor sentiment regarding Ondine Biomedical suggests that many traders are alarmed. The current market sentiment, together with Ondine Biomedical's historical and current headlines, can help investors time the market. In addition, many technical investors use Ondine Biomedical stock news signals to limit their universe of possible portfolio assets.
Ondine Biomedical stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ondine daily returns and investor perception about the current price of Ondine Biomedical as well as its diversification or hedging effects on your existing portfolios.
  
over six months ago at news.google.com         
Ondine Biomedical Full Year 2022 Earnings CA0.10 loss per share - Yahoo Movies Canada
Google News at Macroaxis
over six months ago at news.google.com         
Ondine Biomedicals Strategic Fundraising Move - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Ondine Biomedical Prepares for Major Fundraising - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
HCA beats first-quarter profit estimates on higher patient admissions - Marketscreener.com
Google News at Macroaxis
over six months ago at news.google.com         
Ondine Biomedicals Steriwave Revolutionizes Infection Prevention - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Ondine reports significant financial growth - ShareCast
Google News at Macroaxis
over six months ago at news.google.com         
Ondine Biomedicals Steriwave Debuts in Australia - TipRanks.com - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Ondine Biomedical Inc Announces Steriwave in First Australian Hospital - Yahoo Finance UK
Google News at Macroaxis
over six months ago at news.google.com         
Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK - AccessWire
Google News at Macroaxis
over six months ago at news.google.com         
Ondine Biomedical Inc. Announces Steriwave Authorized for use by HCA UK - Yahoo Finance UK
Google News at Macroaxis
over six months ago at news.google.com         
Appointment of Interim Chief Financial Officer - ShareCast
Google News at Macroaxis
over six months ago at news.google.com         
Ondine Biomedical achieves milestone with NHS trusts adoption of Steriwave - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Ondine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHS - Yahoo Finance U...
Google News at Macroaxis
over six months ago at news.google.com         
Ondine Biomedical Inc. Announces Steriwave Study Shows 77 percent Drop in Antibiotic Use - Yahoo Fin...
Google News at Macroaxis
over six months ago at news.google.com         
BioPharma Credit Stock Price Down 3.4 percent - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ondine Biomedical that are available to investors today. That information is available publicly through Ondine media outlets and privately through word of mouth or via Ondine internal channels. However, regardless of the origin, that massive amount of Ondine data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ondine Biomedical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ondine Biomedical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ondine Biomedical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ondine Biomedical alpha.

Ondine Biomedical Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Ondine Secures C5 million Financing - Yahoo Finance UK
09/24/2024
2
Ondine Continues Commercial Growth - AccessWire
10/28/2024
3
Ondine Biomedical Increases Fundraising Efforts - TipRanks
11/13/2024

Complementary Tools for Ondine Stock analysis

When running Ondine Biomedical's price analysis, check to measure Ondine Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ondine Biomedical is operating at the current time. Most of Ondine Biomedical's value examination focuses on studying past and present price action to predict the probability of Ondine Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ondine Biomedical's price. Additionally, you may evaluate how the addition of Ondine Biomedical to your portfolios can decrease your overall portfolio volatility.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Transaction History
View history of all your transactions and understand their impact on performance